DV
Dividend Vision

GRML — Greenland Mines Ltd

Greenland Mines Ltd (GRML)

Total return is -15.8% over the past 0.5 years, 28.3 points behind SPY at 12.5%.

Greenland Mines Ltd operates in two distinct business segments: cell and gene therapy development, and natural resource exploration. In therapeutics, the company is developing KLTO-202 for amyotrophic lateral sclerosis and KLTO-101 for Alzheimer's disease, along with therapies targeting Parkinson's and other age-related disorders; in natural resources, it explores palladium, gold, and platinum deposits, primarily through the Skaergaard project in Southeast Greenland. The company does not currently distribute dividends and has no expense ratio as it is an operating company rather than a fund.

GRML key facts

Asset type
Stock
Asset class
Equity
Inception date
02/09/2026
Last close
$0.20
Market cap
$31,475,668
Average volume
2045600.0
Beta
2.523
Payout ratio
0.0
Forward P/E
0.0